Citigroup’s Arvinas ARVN Stock Holding History

Citigroup’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-67,500	Closed	-$2.77M	–	7584
2019 Q4	$2.77M	Buy	+67,500	New	+$1.98M	﹤0.01%	2636

Other funds holding ARVN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup's ARVN Position: Q1 2026 in Review

Citigroup reduced its Arvinas (ARVN) stake by 41% in Q1 2026, selling an estimated $213K and leaving 25,122 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #3865.

Citigroup first reported a position in ARVN in Q3 2018 and has held it in 31 quarters since. The position peaked at $5.71M in Q4 2023. 206 funds tracked by Wall St. Rank hold ARVN as of Q1 2026.

Citigroup held 25,122 shares of Arvinas worth $266K as of Q1 2026.
Citigroup sold 17,184 Arvinas shares in Q1 2026, an estimated $213K.
Arvinas made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #3865 holding.
Citigroup first reported a position in Arvinas in Q3 2018 and has held it in 31 quarters since.
Citigroup's Arvinas position peaked at $5.71M in Q4 2023.
206 funds tracked by Wall St. Rank held Arvinas as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.